Regarding "Phenylpropanolamine and Hemorrhagic Stroke in the Hemorrhagic Stroke Project": Mercenary Epidemiology-Data Reanalysis and Reinterpretation for Sponsors With Financial Interest in the Outcome

Annals of Epidemiology

Volumn 16, Issue 7, 2006, Pages 583-585

  Michaels, David ^a,b  

^a The Project on Scientific Knowledge and Public Policy   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG; PHENYLPROPANOLAMINE;

BRAIN HEMORRHAGE; CANCER RISK; CLINICAL RESEARCH; DRUG APPROVAL; DRUG MANUFACTURE; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; HUMAN; LAW; LETTER; MEDICAL LITERATURE; MEDICAL SOCIETY; MEDICAL SPECIALIST; OCCUPATIONAL HEALTH; OCCUPATIONAL SAFETY; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE;

ADOLESCENT; ADULT; APPETITE DEPRESSANTS; CEREBROVASCULAR ACCIDENT; CONFLICT OF INTEREST; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; LAWYERS; MALE; MIDDLE AGED; NASAL DECONGESTANTS; PHENYLPROPANOLAMINE; RESEARCH DESIGN; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33745288766     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2006.04.004     Document Type: Letter

References (29)

1. Stier B.G., and Hennekens C.H. Phenylpropanolamine and hemorrhagic stroke in the hemorrhagic stroke project: A reappraisal in the context of science, the Food and Drug Administration, and the law. Ann Epidemiol 16 (2006) 49-52
2. Horwitz RI, Brass LM, Kernan WN, Viscoli CM. Phenylpropanolamine and Risk of Hemorrhagic Stroke, Final Report of the Hemorrhagic Stroke Project. Available at: http://www.pharm.chula.ac.th/Surachai/academic/Study/PPA%20Final%20Report.pdf. 2000. Accessed May 17, 2006.
3. Kernan W.N., Viscoli C.M., Brass L.M., Broderick J.P., Brott T., Feldmann E., et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 343 (2000) 1826-1832
4. La Grenade L. Testimony at FDA Center for Drug Evaluation and Research, Non Prescription Drugs Advisory Committee, Meeting on Safety Issues of Phenylpropanolamine (PPA) in Over-the-Counter Drug Products. October 19, 2000. Transcript available at: http://www.fda.gov/ohrms/dockets/ac/00/transcripts/3647t1.doc. Accessed May 17, 2006.
5. Center for Drug Evaluation and Research, US Food and Drug Administration. Epidemiologic Review of Phenylpropanolamine Safety Issues. April 30, 1991. Available at: http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3647b1_tab0006_a_EPIReview.pdf. Accessed May 17, 2006.
6. FDA Center for Drug Evaluation and Research, Non Prescription Drugs Advisory Committee, Meeting on Safety Issues of Phenylpropanolamine (PPA) in Over-the-Counter Drug Products. October 19, 2000. Transcript available at: http://www.fda.gov/ohrms/dockets/ac/00/transcripts/3647t1.doc. Accessed.
7. La Grenade L, Nourjah P, Sherman R, Beitz J, Trontell A, Graham D. Estimating Public Health Impact of Adverse Drug Events in Pharmacoepidemiology: Phenylpropanolamine and Hemorrhagic Stroke. Poster presentation at the 2001 FDA Science Forum: Science Across the Boundaries; Washington, DC; February 15-16, 2001.
8. US Food and Drug Administration. Public Health Advisory, Subject: Safety of Phenylpropanolamine. November 6, 2000. Available at: http://www.fda.gov/cder/drug/infopage/ppa/advisory.htm. Accessed May 17, 2006.
9. R.J. Reynolds Co. interoffice memorandum from A.V. Colucci to George Newton (January 2, 1986). Subject: Planning of Strategic Analyses. Bates: 515838456-515838457. Available at: http://tobaccodocuments.org/ness/42840.html. Accessed May 17, 2006.
10. R.J. Reynolds Co. interoffice memorandum from Anthony V., Colucci to George Newton (February 25, 1985). Subject: Consultants and Witness Status. Bates: 507916920-507916921. Available at: http://tobaccodocuments.org/ness/42855.html. Accessed May 17, 2006.
11. Wiggins E.C., and McKenna J.A. Researchers' reactions to compelled disclosure of scientific information. Law & Contemporary Problems 59 (1996) 59-67
12. Alterman T, Austin DF, Boyd P, Buffler PA, Chen VW, Correa P, et al. LA State University Medical Center. 11 Mar 1997. Philip Morris. Bates No. 2063778589/8591. Available at: http://legacy.library.ucsf.edu/tid/bfi05c00. Accessed May 17, 2006.
13. Baba A., Cook D.M., McGarity T.O., and Bero L.A. Legislating "sound science": The role of the tobacco industry. Am J Public Health 95 Suppl 1 (2005) S20-S27
14. Omnibus Consolidated and Emergency Supplemental Appropriations Act, 1999. Pub Law 105-277, October 21, 1998.
15. Dockery D., Pope III C.A., Xu X., Spengler J.D., Ware J.H., Fay M.E., et al. An association between air pollution and mortality in six US cities. N Engl J Med 329 (1993) 1753-1759
16. Pope III C.A., Thun M.J., Namboodiri M.M., Dockery D.W., Evans J.S., Speizer F.E., et al. Particulate air pollution as a predictor of mortality in a prospective study of US adults. Am J Respir Crit Care Med 151 (1995) 669-674
17. Wagner W., and Michaels D. Equal treatment for regulatory science: Extending the controls governing the quality of public research to private research. Am J Law Med 30 (2004) 119-154
18. Levy P., Roth H.D., Hwang P.M., and Powers T.E. Beryllium and lung cancer: A reanalysis of a NIOSH cohort mortality study. Inhal Toxicol 14 (2001) 1003-1015
19. Anonymous. Reanalysis of Lung Cancer Mortality Study for Workers in the Baltimore Chromium Production Facility. Exponent Inc., Irvine, CA, November 2002. Available at: http://dockets.osha.gov/vg001/V026A/01/13/72.PDF. Accessed May 17, 2006.
20. Infante P.F., Rinsky R.A., Wagoner J.K., and Young R.J. Leukaemia in benzene workers. Lancet 2 (1977) 76-78
21. 29 CFR 1910.1028.
22. Paustenbach D.J., Price P.S., Ollison W., Blank C., Jernigan J.D., Bass R.D., et al. Reevaluation of benzene exposure for the Pliofilm (rubberworker) cohort (1936-1976). J Toxicol Environ Health 36 (1992) 177-231
23. Paustenbach D.J., Bass R.D., and Price P. Benzene toxicity and risk assessment, 1972-1992: Implications for future regulation. Environ Health Perspect 101 Suppl 6 (1993) S177-S200
24. Lan Q., Zhang L., Li G., Vermeulen R., Weinberg R.S., Dosemeci M., et al. Hematotoxicity in workers exposed to low levels of benzene. Science 306 (2004) 1774-1776
25. Hayes R.B., Songnian Y., Dosemeci M., and Linet M. Benzene and lymphohematopoietic malignancies in humans. Am J Ind Med 40 (2001) 117-126
26. Neutra R.R., Cohen A., Fletcher T., Michaels M., Richter E.D., and Soskolne C.L. Toward guidelines for the ethical reanalysis and reinterpretation of another's research. Epidemiol 17 (2006) 335-338
27. Health Effects Institute. Reanalysis of the Harvard Six Cities Study and the American Cancer Society Study of Particulate Air Pollution and Mortality. A Special Report of the Institute's Particle Epidemiology Reanalysis Project. Final version, July 2000. Available at: http://www.healtheffects.org/Pubs/Rean-Statement.pdf. Accessed May 17, 2006.
28. Michaels D., and Monforton C. Manufacturing uncertainty: Contested science and the protection of the public's health and environment. Am J Public Health 95 Suppl 1 (2005) S39-S48
29. Michaels D. Doubt is their product. Sci Am 292 (2005) 74-79